M 177 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint M 177 is White, Round and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 177

Divalproex sodium extended-release 250 mg M 177

Divalproex sodium extended-release 250 mg M 177 Front

Divalproex sodium extended-release 250 mg M 177 Back

Divalproex Sodium Extended-Release

Imprint: M 177
Strength: 250 mg
Color: White
Size: 12.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
Inactive Ingredients: ammonia, silicon dioxide, dibutyl sebacate, oleic acid, polydextrose, microcrystalline cellulose, titanium dioxide, triacetin
Note: Inactive ingredients may vary.